Serina Therapeutics CEO Discusses Parkinson's Drug Progress in Webinar
What happened
Tribe Public LLC hosted a webinar on September 1, 2026, featuring Serina Therapeutics' CEO, Steven Ledger. The presentation, titled "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress," was streamed using Zoom. Serina Therapeutics is a clinical-stage biotechnology company developing treatments for neurological diseases.
From manilatimes.net
Why it matters
The event provided an update on SER-252, Serina Therapeutics' lead program for advanced Parkinson’s disease, which utilizes the company's proprietary POZ Platform™ technology. This presentation highlights the company's pipeline and clinical progress in the neurological drug market.
From manilatimes.net
Who's involved
- Mission DistrictFacilitated the corporate sponsored global event
- SECClinical-stage biotechnology company developing drug candidates for neurological diseases
- ZoomProvided the streaming platform for the CEO presentation
Keep exploring
The entities involved
-
Zoom
stream
Nothing else this week.
-
San Francisco
consolidated city and county in California, United States
- High-end dining scene highlights how chefs are integrating local produce and cultural trends into their high-end establishments across various locations.
- The California Coastal Commission is reviewing the restoration of the Upper Great Highway, where voters are considering allowing weekday vehicle access.